Mar 16, 2023 / 12:00PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Good morning, everyone. My name is Gena Wang. I'm SMID-cap biotech analyst at Barclays. Welcome to Barclays Global Healthcare Conference. Today is the last day, and I hope everyone had a very productive meetings -- all having additional productive meetings. It is my great pleasure to introduce today's first presenting company, Alnylam. With us today, we have Jeff Poulton, Chief Financial Officer; also Eric Green, SVP, Head of Development Profiles. Thank you for coming to our conference.
Jeffrey V. Poulton - Alnylam Pharmaceuticals, Inc. - CFO & Executive VP
Thank you. Thanks to Barclays for having us. It's always nice to be in Miami in this time of year.
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Yes, certainly better than Boston.
Jeffrey V. Poulton - Alnylam Pharmaceuticals, Inc. - CFO & Executive VP
Much better.
Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot